Glen Eagle Advisors, LLC Davita Inc. Transaction History

Glen Eagle Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$126.11 - $147.14 $9,332 - $10,888	-74 Closed	0 $0
Q3 2020 Aug 13, 2024	SELL	$79.57 - $91.84 $5,888 - $6,796	-74 Closed	0 $0
Q1 2019 Aug 13, 2024	BUY	$49.95 - $59.21 $3,696 - $4,381	74 New	74 $4.02 Million
Q2 2018 Aug 13, 2024	SELL	$62.77 - $73.47 $301,672 - $353,096	-4,806 Reduced 98.48%	74 $5.14 Million
Q1 2018 Aug 14, 2024	BUY	$65.0 - $80.03 $4,810 - $5,922	74 New	74 $4.88 Million
Q1 2018 Aug 13, 2024	BUY	$65.0 - $80.03 $312,390 - $384,624	4,806 Added 6494.59%	4,880 $4.88 Million
Q3 2017 Aug 13, 2024	BUY	$56.13 - $64.78 $4,153 - $4,793	74 New	74 $4.4 Million
Q4 2016 Aug 12, 2024	BUY	N/A	74	74 $4.75 Million

626

76.4M

1.16M

760K

Ticker DVA
Exchange NYSE
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 91,300,000
Market Cap $13.7B
Description
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Glen Eagle Advisors, LLC with notifications on news.